Metabolic Health
CGM Devices for Biohackers Ranked by Evidence in 2026
A head-to-head review of 10 CGM devices for healthy adults, weighing real-world accuracy data against limited longevity evidence.
Revisione
13 mag 2026 0
Argomento
Diabete
Type 1 and type 2 diabetes, insulin resistance, glucose metabolism, and metabolic health
266 articoli
Metabolic Health
NIH Funds Pancreas Atlas and Heart Risk Models Targeting Age-Related Disease
Three NIH-funded studies this week tackle metabolic decline, cardiac risk, and brain tumors — all with aging implications.
Comunicato stampa
13 mag 2026 0
Metabolic Health
Cochrane Review Protocol Sets Stage for Definitive Insulin Regimen Comparison in Type 1 Diabetes
A major Cochrane network meta-analysis protocol will rank all insulin regimens by efficacy and safety for adults with type 1 diabetes.
Articolo scientifico
13 mag 2026 0
Metabolic Health
SGLT2 Inhibitors May Shield Kidneys From Acute Injury Through Multiple Mechanisms
A comprehensive review finds SGLT2 inhibitors reduce AKI risk in humans via hemodynamic, metabolic, and cellular protective pathways.
Articolo scientifico
12 mag 2026 0
Metabolic Health
CGMs for Longevity Seekers: Real Benefits, Real Limits and What the Evidence Actually Shows
Expert reviews of top CGM platforms reveal genuine metabolic insights — but no proof they extend lifespan in healthy adults.
Revisione
12 mag 2026 0
Metabolic Health
Skin-Worn Microneedle Sensors Track Glucose and Metabolites Without Blood Draws
Wearable microneedle patches tap interstitial fluid to monitor glucose, lactate, and electrolytes in real time — no needles, no lab.
Articolo scientifico
11 mag 2026 0
Metabolic Health
Premium
# Il Manuale Molecolare di AMPK: Meccanismi alla Base del Rilevamento dell'Energia Cellulare
Vai più a fondo su come AMPK rileva lo stress energetico, attiva le chinasi a monte e coordina il metabolismo, l'autofagia e i percorsi della longevità a livello molecolare.
TutorialIntermedio
9 mag 2026 0
Metabolic Health
FDA Approves First Oral GLP-1 Weight Loss Pill Orforglipron
Foundayo (orforglipron) becomes the first oral GLP-1 receptor agonist approved for obesity, offering a pill alternative to injectable Wegovy.
Approvazione farmaco
9 mag 2026 0
Metabolic Health
Single Molecule Activates Five Receptors to Target Obesity and Metabolic Disease
A novel conjugate merges GLP-1/GIP incretin signaling with pan-PPAR activation in one molecule, potentially revolutionizing metabolic therapy.
Articolo scientifico
9 mag 2026 0
Metabolic Health
Premium
Il Misuratore d'Energia del Tuo Corpo: Come AMPK Ti Mantiene in Forma
Scopri AMPK — l'interruttore principale all'interno delle tue cellule che monitora i livelli di energia e attiva potenti risposte anti-invecchiamento quando viene stimolato.
TutorialPrincipiante
8 mag 2026 0
Metabolic Health
CGM Devices for Longevity Biohacking Reviewed: What the Evidence Actually Shows
Six leading CGM platforms compared on accuracy, evidence quality, and longevity claims — most fall short of the hype.
Revisione
8 mag 2026 0
Metabolic Health
Gut Bypass Signals Predict Blood Sugar Control Within Days of Surgery
Early bile acid and incretin responses after duodeno-ileal diversion may forecast long-term glycaemic outcomes in metabolic disease.
Articolo scientifico
7 mag 2026 0